Great write-up OTC, thanks for putting that together! To your top 5 list I would add another (perhaps a top 10):
CureVac Market Cap $12.44B PPS $66.82; "CVAC" on NASDAQ
CureVac is a clinical stage biotech developing mRNA based medicines (including oncology) that has collaborated with J&J, GSK, Sanofi, BI, and the Cancer Research Institute.